Cutaneous lupus erythematosus simulating squamous neoplasia: The clinicopathologic conundrum and histopathologic pitfalls - 19/08/11
Correspondence to: Wain L. White, MD, Greensboro Pathology Associates, PA, 706 Green Valley Rd, Suite 104, Greensboro, NC 27408.Chapel Hill, Winston-Salem, and Greensboro, North Carolina; Roanoke, Virginia; and Lexington, Kentucky
Abstract |
Background |
The clinical distribution and character of cutaneous lupus erythematosus lesions can simulate squamous neoplasms, leading physicians to submit a shave biopsy specimen with a differential diagnosis of squamous neoplasm.
Objective |
Our aim was to describe histologic features of interface dermatitis that cause difficulty in distinguishing between cutaneous lupus erythematosus and squamous neoplasia in shave biopsy specimens and to identify distinguishing criteria.
Methods |
Twenty-six biopsy specimens from 10 patients initially diagnosed with squamous neoplasia that ultimately proved to be cutaneous lupus erythematosus were identified. Comparisons were made of these to 38 control biopsies of chronic cutaneous lupus erythematosus and 34 control biopsies of keratoses/carcinomas without lupus. All biopsies were scored (0 or 1: absent or present) with respect to 11 histologic criteria.
Results |
The criteria of perifollicular inflammation, follicular plugging, vacuolar interface change, compact orthokeratosis, and acrosyringeal inflammation were significantly more common in the lupus cases than in the keratoses/carcinomas controls. The mean lupus case score was 6.88, lupus control score 6.55, and keratoses/carcinomas control score 5.08.
Limitations |
A limited number of patients were studied. Microscopic observations and assumptions with inherent subjectivity were used in establishing the histologic scores.
Conclusion |
Use of the criteria presented, although not absolute, should alert one to the possibility of lupus in an atypical squamous proliferation, especially in suspected squamous neoplasms that worsen or recur after therapy.
Le texte complet de cet article est disponible en PDF.Abbreviations used : CLE, DLE, LE
Plan
| Funding sources: None. Conflicts of interest: None declared. Reprints are not available from the authors. |
Vol 56 - N° 6
P. 1013-1020 - juin 2007 Retour au numéro
Article précédent
- Mast cell distribution, activation, and phenotype in xanthoma
- Masaaki Matsumoto, Sawa Kunimitsu, Kana Wada, Mitsunori Ikeda, Akira Keyama, Hajime Kodama
- Folliculosebaceous smooth muscle hamartoma
- Payam Saadat, Arvin Doostan, Manjunath S. Vadmal
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?